| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |